Gastric Cancer
Conditions
Interventions
Experimental group:Chemotherapy with the SOX regimen was administered simultaneously along with the administration of the Ziyin Huatan Recipe
Control group:SOX chemotherapy regimen
Sponsors
Department of Traditional Chinese Medicine The Second Affiliated Hospital of Naval Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 95 Years
Inclusion criteria
Inclusion criteria: (1) Age 18 or above gender not limited; (2) For patients diagnosed with gastric cancer by cytology or pathology the TNM clinical stage is stage III; (3) Meet the diagnostic criteria for "insufficient stomach Yin" in traditional Chinese medicine; (4) Has undergone radical resection of gastric cancer; (5) Evaluated by the multidisciplinary collaboration group for gastric cancer as suitable for postoperative adjuvant chemotherapy; (6) The Eastern Cooperative Oncology Group (ECOG) score of the United States is =2 points and the expected survival period is =6 months; (7) Voluntarily sign the informed consent form for this study.
Exclusion criteria
Exclusion criteria: (1) Patients with radiotherapy plans or a history of radiotherapy; (2) The patient refused to receive postoperative adjuvant chemotherapy; (3) Patients with severe organic diseases such as liver and kidney insufficiency severe autoimmune diseases and chronic hematological diseases; (4) Disabled patients with intellectual or other impairments who are unable to cooperate in clinical trials; (5) Those who have a known history of allergy to the test drug or any of its related components; (6) Patients with other primary malignant tumor diseases; (7) Pregnant or planning to become pregnant women and lactating women; (8) Diseases medical conditions or organ system dysfunction that are judged by the researcher as endangering the patient's life as well as any circumstances that may endanger the safety of the subjects or put the research results at an inappropriate risk and other circumstances that the researcher deems inappropriate to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Disease-free survival period; | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptom Scoring Table for Insufficient Stomach Yin;The MD Anderson Symptom Inventory;Chemotherapy completion rate;Blood Metabolomics Testing; | — |
Countries
China
Contacts
Public ContactXiaoqiang Yue
The Second Affiliated Hospital of the PLA Navy Medical University
Outcome results
None listed